BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang K, Li H, Kwong WJ, Antman EM, Ruff CT, Giugliano RP, Cohen DJ, Magnuson EA; ENGAGE AF‐TIMI 48 Trial Investigators. Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF-TIMI 48 Trial. J Am Heart Assoc 2017;6:e006703. [PMID: 28862934 DOI: 10.1161/JAHA.117.006703] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Jacobs MS, Adeoye AM, Owolabi MO, Tieleman RG, Postma MJ, Van Hulst M. Screening for Atrial Fibrillation in Sub-Saharan Africa: A Health Economic Evaluation to Assess the Feasibility in Nigeria. Glob Heart 2021;16:80. [PMID: 34900571 DOI: 10.5334/gh.893] [Reference Citation Analysis]
2 Pasea L, Chung SC, Pujades-Rodriguez M, Shah AD, Alvarez-Madrazo S, Allan V, Teo JT, Bean D, Sofat R, Dobson R, Banerjee A, Patel RS, Timmis A, Denaxas S, Hemingway H. Bleeding in cardiac patients prescribed antithrombotic drugs: electronic health record phenotyping algorithms, incidence, trends and prognosis. BMC Med 2019;17:206. [PMID: 31744503 DOI: 10.1186/s12916-019-1438-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Rivolo S, Di Fusco M, Polanco C, Kang A, Dhanda D, Savone M, Skandamis A, Kongnakorn T, Soto J. Cost-effectiveness analysis of apixaban versus vitamin K antagonists for antithrombotic therapy in patients with atrial fibrillation after acute coronary syndrome or percutaneous coronary intervention in Spain. PLoS One 2021;16:e0259251. [PMID: 34767564 DOI: 10.1371/journal.pone.0259251] [Reference Citation Analysis]
4 Xu Y, Gomes T, Wells PS, Pequeno P, Johnson A, Sholzberg M. Evaluation of definitions for oral anticoagulant-associated major bleeding: A population-based cohort study. Thrombosis Research 2022. [DOI: 10.1016/j.thromres.2022.02.018] [Reference Citation Analysis]
5 Proietti M, Rivera-Caravaca JM, Esteve-Pastor MA, Romiti GF, Marin F, Lip GYH. Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS-BLED and GARFIELD-AF Bleeding Scores. J Am Heart Assoc 2018;7:e009766. [PMID: 30371183 DOI: 10.1161/JAHA.118.009766] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
6 Edwards SJ, Wakefield V, Jhita T, Kew K, Cain P, Marceniuk G. Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke: a systematic review and economic evaluation. Health Technol Assess 2020;24:1-184. [PMID: 31944175 DOI: 10.3310/hta24050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Piersma-Wichers M, Elling T, de Vries-Bots AMB, Kooistra HAM, Meijer K. Convenience and satisfaction in direct oral anticoagulant-treated patients with atrial fibrillation. Res Pract Thromb Haemost 2021;5:e12577. [PMID: 34430791 DOI: 10.1002/rth2.12577] [Reference Citation Analysis]